BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1768838)

  • 1. PAF-acetylhydrolase, predominantly present in LDL in healthy subjects, is associated with HDL in a patient with LDL deficiency.
    Surya II; Mommersteeg M; Erkelens DW; Akkerman JW
    J Lipid Mediat; 1991; 3(1):27-38. PubMed ID: 1768838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoproteins alter the catalytic behavior of the platelet-activating factor acetylhydrolase in human plasma.
    Stafforini DM; Carter ME; Zimmerman GA; McIntyre TM; Prescott SM
    Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2393-7. PubMed ID: 2928339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor.
    Stafforini DM; McIntyre TM; Carter ME; Prescott SM
    J Biol Chem; 1987 Mar; 262(9):4215-22. PubMed ID: 3549727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of platelet-activating factor in systemic lupus erythematosus.
    Tetta C; Bussolino F; Modena V; Montrucchio G; Segoloni G; Pescarmona G; Camussi G
    Int Arch Allergy Appl Immunol; 1990; 91(3):244-56. PubMed ID: 2354868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures.
    Milionis HJ; Elisaf MS; Karabina SA; Bairaktari E; Tselepis AD; Siamopoulos KC
    Kidney Int; 1999 Dec; 56(6):2276-85. PubMed ID: 10594806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-density lipoprotein inhibits the production of platelet activating factor acetylhydrolase by HepG2 cells.
    Satoh K; Imaizumi T; Yoshida H; Takamatsu S
    J Lab Clin Med; 1994 Feb; 123(2):225-31. PubMed ID: 8301198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia.
    Karabina SA; Elisaf M; Bairaktari E; Tzallas C; Siamopoulos KC; Tselepis AD
    Eur J Clin Invest; 1997 Jul; 27(7):595-602. PubMed ID: 9263748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of individual lipoproteins to the degradation of platelet-activating factor in human serum.
    Ostermann G; Kostner GM; Gries A; Malle E; Till U
    Haemostasis; 1989; 19(3):160-8. PubMed ID: 2744632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility.
    McCall MR; La Belle M; Forte TM; Krauss RM; Takanami Y; Tribble DL
    Biochim Biophys Acta; 1999 Jan; 1437(1):23-36. PubMed ID: 9931415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver cells secrete the plasma form of platelet-activating factor acetylhydrolase.
    Tarbet EB; Stafforini DM; Elstad MR; Zimmerman GA; McIntyre TM; Prescott SM
    J Biol Chem; 1991 Sep; 266(25):16667-73. PubMed ID: 1653245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme.
    Tselepis AD; Dentan C; Karabina SA; Chapman MJ; Ninio E
    Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1764-73. PubMed ID: 7583554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein.
    Tsoukatos DC; Liapikos TA; Tselepis AD; Chapman MJ; Ninio E
    Biochem J; 2001 Jul; 357(Pt 2):457-64. PubMed ID: 11439095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein.
    Stafforini DM; Tjoelker LW; McCormick SP; Vaitkus D; McIntyre TM; Gray PW; Young SG; Prescott SM
    J Biol Chem; 1999 Mar; 274(11):7018-24. PubMed ID: 10066756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All ApoB-containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified. Modulation of lipoprotein bioactivity by platelet-activating factor acetylhydrolase.
    Lee C; Sigari F; Segrado T; Hörkkö S; Hama S; Subbaiah PV; Miwa M; Navab M; Witztum JL; Reaven PD
    Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1437-46. PubMed ID: 10364074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor.
    Ambrosio G; Oriente A; Napoli C; Palumbo G; Chiariello P; Marone G; Condorelli M; Chiariello M; Triggiani M
    J Clin Invest; 1994 Jun; 93(6):2408-16. PubMed ID: 8200975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia.
    Tsimihodimos V; Karabina SA; Tambaki AP; Bairaktari E; Miltiadous G; Goudevenos JA; Cariolou MA; Chapman MJ; Tselepis AD; Elisaf M
    J Lipid Res; 2002 Feb; 43(2):256-63. PubMed ID: 11861667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-activating factor acetylhydrolase is mainly associated with electronegative low-density lipoprotein subfraction.
    Benítez S; Sánchez-Quesada JL; Ribas V; Jorba O; Blanco-Vaca F; González-Sastre F; Ordóñez-Llanos J
    Circulation; 2003 Jul; 108(1):92-6. PubMed ID: 12821559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid substitution therapy induces high-density lipoprotein-associated platelet-activating factor-acetylhydrolase in patients with subclinical hypothyroidism: a potential antiatherogenic effect.
    Milionis HJ; Tambaki AP; Kanioglou CN; Elisaf MS; Tselepis AD; Tsatsoulis A
    Thyroid; 2005 May; 15(5):455-60. PubMed ID: 15929667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human plasma platelet-activating factor acetylhydrolase. Purification and properties.
    Stafforini DM; Prescott SM; McIntyre TM
    J Biol Chem; 1987 Mar; 262(9):4223-30. PubMed ID: 3558407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mouse plasma PAF acetylhydrolase: II. It consists of two enzymes both associated with the HDL.
    Tsaoussis V; Vakirtzi-Lemonias C
    J Lipid Mediat Cell Signal; 1994 May; 9(3):317-31. PubMed ID: 7921790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.